HIV-DRI

Providing Options – Empowering Practitioners

Drug resistance is the major contributing factor in the diminished efficacy of many therapeutic agents currently utilized throughout the world to treat HIV.
The HIV-DRI Roundtable Consensus ConferenceTM was a key component of the HIV-DRI Initiative developed in conjunction with the American Society for Microbiology (ASM).

This Case Study presents the scope of the effort and the nature of coordination involved with a professional medical society. The featured video clips provide examples of expert impact on different audience segments.

Raising Awareness of HIV Drug Resistance

Benefits of HIV-DRI to Clinicians and Patient

MRSA-i

Addressing the Challenges in the Management and Treatment of MRSA

The MRSA-i Roundtable Consensus ConferenceTM was a featured aspect of the MRSA (Methicillin-Resistant Staphylococcus Aureus) Initiative developed in conjunction with the American Society for Microbiology (ASM).

The program was established to focus on the complex and critical issues related to MRSA facing the medical community and the population as a whole. Understanding that local, regional and national resources for addressing MRSA can vary, the program focused on presenting a range of options within each key element of the MRSA Initiative (MRSA-I).

The MRSA-i Consensus ConferenceTM featured a world-renown group of experts to discuss the latest data on the management of MRSA infections. Below are sample video clips demonstrating how the “decoding” of complex issues into manageable segments results in material that is immediately useful to clinicians.

Addressing the Challenges in the Management and Treatment of MRSA